Dimethaid

DMX-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about DMX-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
September 15, 2005
New management. Doesn't follow this company actively because it doesn't have much in the way of earnings. In the bottom 10% of his database.
Show full opinionHide full opinion
Dimethaid (DMX-T)
September 15, 2005
New management. Doesn't follow this company actively because it doesn't have much in the way of earnings. In the bottom 10% of his database.
DON'T BUY
DON'T BUY
January 25, 2005
Very much news driven. Speculative. Need a very strong stomach.
Show full opinionHide full opinion
Dimethaid (DMX-T)
January 25, 2005
Very much news driven. Speculative. Need a very strong stomach.
DON'T BUY
DON'T BUY
November 27, 2003
Looked like it was going to break out of a 200-day moving average but fell back. Did a special warrant financing in October for sales/marketing of Pennsaid. FDA approval has been pending for a long time. Caution.
Show full opinionHide full opinion
Dimethaid (DMX-T)
November 27, 2003
Looked like it was going to break out of a 200-day moving average but fell back. Did a special warrant financing in October for sales/marketing of Pennsaid. FDA approval has been pending for a long time. Caution.
DON'T BUY
DON'T BUY
July 3, 2003
Has been losing value for some time. Need to have a lot of faith. They are still waiting for a green light from the FDA. The big risk is their inability to move sales.
Show full opinionHide full opinion
Dimethaid (DMX-T)
July 3, 2003
Has been losing value for some time. Need to have a lot of faith. They are still waiting for a green light from the FDA. The big risk is their inability to move sales.
BUY
BUY
March 27, 2003
A this point, its a reasonable bet.
Show full opinionHide full opinion
Dimethaid (DMX-T)
March 27, 2003
A this point, its a reasonable bet.
BUY
BUY
March 19, 2001
Approaching commercialization.
Show full opinionHide full opinion
Dimethaid (DMX-T)
March 19, 2001
Approaching commercialization.
WATCH
WATCH
January 2, 2001
Attractive, but wait for partnership deal with Johnson & Johnson
Show full opinionHide full opinion
Dimethaid (DMX-T)
January 2, 2001
Attractive, but wait for partnership deal with Johnson & Johnson
BUY
BUY
November 29, 2000
Not a big enough following but should be OK
Show full opinionHide full opinion
Dimethaid (DMX-T)
November 29, 2000
Not a big enough following but should be OK
BUY
BUY
October 13, 2000
Good techs. Have to convince the Feds its a good way to deliver pain relief
Show full opinionHide full opinion
Dimethaid (DMX-T)
October 13, 2000
Good techs. Have to convince the Feds its a good way to deliver pain relief
Showing 1 to 9 of 9 entries
  • «
  • 1
  • »

Dimethaid(DMX-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Dimethaid is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Dimethaid(DMX-T) Frequently Asked Questions

What is Dimethaid stock symbol?

Dimethaid is a OTC stock, trading under the symbol DMX-T on the (). It is usually referred to as or DMX-T

Is Dimethaid a buy or a sell?

In the last year, there was no coverage of Dimethaid published on Stockchase.

Is Dimethaid a good investment or a top pick?

Dimethaid was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Dimethaid.

Why is Dimethaid stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Dimethaid worth watching?

0 stock analysts on Stockchase covered Dimethaid In the last year. It is a trending stock that is worth watching.

What is Dimethaid stock price?

On , Dimethaid (DMX-T) stock closed at a price of $.